Top

A Focus on the Role of Patient Navigators in the Diagnosis and Management of Early-Stage NSCLC

Panelists discuss how a multidisciplinary team (MDT) approach to resectable non–small cell lung cancer (NSCLC) involves an initial diagnostic workup with imaging (CT, PET-CT), histologic confirmation via biopsy, staging with mediastinal assessment (endobronchial ultrasound or mediastinoscopy), and timely molecular testing (eg, EGFR, ALK, PD-L1) integrated early in the process to guide perioperative treatment decisions.

Video content above is prompted by the following: Diagnostic Workup for Resectable NSCLC: An MDT Approach Initial Evaluation and Clinical Assessment Tissue Diagnosis and Staging Molecular and Biomarker Testing MDT Discussion and Treatment Planning Postoperative Follow-Up and Surveillance This streamlined diagnostic approach ensures that molecular testing is integrated early, allowing for timely and personalized treatment decisions for patients with resectable NSCLC..